ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.869,36
0,78%
S&P 500
5.301,19
1,04%
Dow Jones
39.835,02
0,70%
Euro vs US Dollar
1,08772
0,58%
Bitcoin
65.400,01
6,26%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Avant Immunotherapeutics (MM) (AVAN)

  7. Avant Immunotherapeutics (MM) (AVAN) News

AVAN

Avant Immunotherapeutics (MM) (AVAN)

Avant Immunotherapeutics (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AVAN
DatumZeitQuelleÜberschriftSymbolFirma
29/09/200823h02Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200817h43Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200817h42Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200817h42Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200817h42Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200817h41Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200817h41Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
29/09/200814h00Business WireAVANT Immunotherapeutics Announces Name Change to Celldex TherapeuticsNASDAQ:AVANAvant Immunotherapeutics (MM)
24/09/200800h14Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
19/09/200816h28Edgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/09/200822h00Business WireAVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23NASDAQ:AVANAvant Immunotherapeutics (MM)
13/08/200822h53Edgar (US Regulatory)Avant Immunotherapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:AVANAvant Immunotherapeutics (MM)
08/08/200822h16Business WireAVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
06/08/200816h52Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
06/08/200814h46Business WireCORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
06/08/200814h00Business WireAVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
04/08/200819h56Business WireAVANT to Report Second Quarter 2008 Financial Results on August 6, 2008NASDAQ:AVANAvant Immunotherapeutics (MM)
28/07/200823h25Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/07/200822h59Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/07/200820h05Edgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
26/06/200822h47Edgar (US Regulatory)Avant Immunotherapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVANAvant Immunotherapeutics (MM)
18/06/200817h13Edgar (US Regulatory)Avant Immunotherapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:AVANAvant Immunotherapeutics (MM)
11/06/200814h00Business WireAVANT Announces Vaccine Adjuvant Licenses with 3MNASDAQ:AVANAvant Immunotherapeutics (MM)
09/06/200822h29Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
04/06/200816h00Business WireAVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
04/06/200813h00Business WireNIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera VaccineNASDAQ:AVANAvant Immunotherapeutics (MM)
03/06/200814h30MarketwiredMarket Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN – NACEL Energy Achieves Objectives With 640 MW Wind Power in DeNASDAQ:AVANAvant Immunotherapeutics (MM)
02/06/200822h56Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
02/06/200820h32MarketwiredNew Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYONDNASDAQ:AVANAvant Immunotherapeutics (MM)
30/05/200819h54Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:AVAN

Kürzlich von Ihnen besucht

LBNK
DHABICOINUSDT
Dhabi Coin
COIN
NMTBTC
HUOB
BOBUSDT
BOB
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten